PATHOGENESIS OF POSTMENOPAUSAL OSTEOPOROSIS

被引:8
|
作者
LINDSAY, R [1 ]
机构
[1] HELEN HAYES HOSP,CTR REG BONE,W HAVERSTRAW,NY 10993
来源
BAILLIERES CLINICAL RHEUMATOLOGY | 1993年 / 7卷 / 03期
关键词
D O I
10.1016/S0950-3579(05)80075-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a disorder of ageing that shares with other disorders of ageing a multifactorial pathogenesis. The important factors for osteoporosis include the diet, life-style and intercurrent factors such as disease. However, it is clear that loss of ovarian function is an important determinant of bone loss, and oestrogen appears to be the key factor involved. Thus, not only does loss of ovarian function result in bone loss, it can be stopped by adequate oestrogen intervention. Numerous techniques are available to measure bone mass non-invasively and to estimate the risk of future fracture. Thus, for the postmenopausal woman who is concerned about osteoporosis, and who is willing to accept intervention to prevent the disease, bone mass measurement allows the clinician to determine the risk of future osteoporotic fracture and to provide intervention if required. Future studies may elucidate whether determination of skeletal remodelling using biochemistry adds significantly to risk determination. This may be required when considering agents other than oestrogen for intervention among asymptomatic women, as these agents primarily affect the skeleton, while the effects of oestrogen are wide ranging in the body. © 1993 Baillière Tindall.
引用
收藏
页码:499 / 513
页数:15
相关论文
共 50 条
  • [1] Pathogenesis of Postmenopausal Osteoporosis
    Raisz L.G.
    Reviews in Endocrine and Metabolic Disorders, 2001, 2 (1) : 5 - 12
  • [2] PATHOGENESIS AND PROPHYLAXIS OF POSTMENOPAUSAL OSTEOPOROSIS
    RINGE, JD
    MEDIZINISCHE KLINIK, 1985, 80 (20) : 555 - 558
  • [3] INSULIN RESISTANCE AND PATHOGENESIS OF POSTMENOPAUSAL OSTEOPOROSIS
    Greere, D. I. I.
    Grigorescu, F.
    Manda, D.
    Lautier, C.
    Poiana, C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2023, 19 (03) : 349 - 363
  • [4] Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
    Pacifici, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (08) : 1043 - 1051
  • [5] PREVALENCE, PATHOGENESIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    CRILLY, R
    HORSMAN, A
    MARSHALL, DH
    NORDIN, BEC
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (01): : 24 - 30
  • [6] Pathogenesis and prevention of postmenopausal osteoporosis .1. Diagnosis and pathogenesis
    Zittermann, A
    ERNAHRUNGS-UMSCHAU, 1997, 44 (01): : 10 - &
  • [7] ROLE OF HORMONAL FACTORS IN PATHOGENESIS OF POSTMENOPAUSAL OSTEOPOROSIS
    RIGGS, BL
    JOWSEY, J
    KELLY, PJ
    ARNAUD, CD
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1976, 12 (07): : 615 - 619
  • [8] Novel approach for pathogenesis of osteoporosis in ovariectomized rats as a model of postmenopausal osteoporosis
    Saleh, NermineK
    Nassef, Noha A.
    Shawky, Mona K.
    Elshishiny, Menna, I
    Saleh, Hanan A.
    EXPERIMENTAL GERONTOLOGY, 2020, 137
  • [9] Postmenopausal osteoporosis: a bioinformatics-integrated experimental study the pathogenesis
    Tian, Shuo
    Song, Yagang
    Song, Jinping
    Guo, Lin
    Peng, Mengfan
    Wu, Xiangxiang
    Qiao, Jingyi
    Bai, Ming
    Miao, Mingsan
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 39 (02) : 1088 - 1106
  • [10] Pathogenesis and prevention of postmenopausal osteoporosis .2. Preventive measures
    Zittermann, A
    ERNAHRUNGS-UMSCHAU, 1997, 44 (02): : 51 - &